US Patent No. 11,761,020
IND package submitted to FDA.
International Publication Number WO 2022/081839 A1
FDA responded to our pre-IND package by providing its clear and complete guidance, which was sufficient for us to finalize the IND package.
U.S. Provisional Application No. 63/092,239 was electronically filed with the U.S. Patent Office.
Service Agreement was signed with Fred Hutch as Contracted Manufacturing Organization (CMO).
Nonclinical and Clinical US Regulatory Strategies was set up by Weinberg.
Copyright © 2024 Aavocyte, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.